Avantor, Inc. Share Price

Equities

AVTR

US05352A1007

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 10:47:32 03/06/2024 pm IST 5-day change 1st Jan Change
24.06 USD -0.06% Intraday chart for Avantor, Inc. -0.25% +5.48%
Sales 2024 * 6.94B 576B Sales 2025 * 7.32B 608B Capitalization 16.36B 1,359B
Net income 2024 * 423M 35.14B Net income 2025 * 621M 51.58B EV / Sales 2024 * 3.03 x
Net Debt 2024 * 4.65B 386B Net Debt 2025 * 3.89B 323B EV / Sales 2025 * 2.77 x
P/E ratio 2024 *
35.7 x
P/E ratio 2025 *
25.4 x
Employees 14,500
Yield 2024 *
-
Yield 2025 *
-
Free-Float 96.68%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 01/14/01
Director of Finance/CFO 54 07/23/07
Compliance Officer - -
Members of the board TitleAgeSince
Director/Board Member 54 01/21/01
Director/Board Member 68 07/20/07
Chairman 66 01/17/01
More insiders
Date Price Change Volume
03/24/03 24.06 -0.06% 2 067 518
31/24/31 24.08 +2.03% 9,510,806
30/24/30 23.6 +0.13% 8,280,657
29/24/29 23.57 -0.59% 4,422,124
28/24/28 23.71 -1.78% 4,143,588

Delayed Quote Nyse, June 03, 2024 at 10:32 pm IST

More quotes
Avantor, Inc. is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education and government, and advanced technologies & applied materials industries. Its products include materials and consumables, equipment and instrumentation, and services and specialty procurement. Materials and consumables include chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits and education and microbiology and clinical trial kits. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, freezers, biological safety cabinets and critical environment supplies. Services and specialty procurement include onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
24.08 USD
Average target price
27.77 USD
Spread / Average Target
+15.31%
Consensus